NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...
NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...
Consensus Offers Clinicians Structured Guidance on When and How to Reassess, Taper, or Discontinue Psychotropic ...
SIMI VALLEY, CA - February 25, 2026 - PRESSADVANTAGE - All In Solutions Detox, a leading inpatient treatment center, ...
Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery. A new SDL system, called LUMI-lab, combines large-scale molecular ...
Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Fairfield County Workforce Center will host three free training sessions to help employees strengthen communication and ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals as well as alleviating animal suffering. But ...
SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...
Abstract: Drug-target affinity (DTA) prediction plays a crucial role in accelerating the drug development process. Although deep learning-based models achieve strong performance in benchmark datasets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results